Key signaling molecules such as AMP-activated protein kinase (AMPK) and Glycogen synthase kinase 3β (GSK3β) are central to major AD features like amyloid-β metabolism and tau hyperphosphorylation. Here, MAPT is linked to Alzheimer disease.